Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (ABRYSVO) | PFIZER\WYETH | 1 | LG9829 | IM / LA |
Reported Symptoms: 10002424:ANGIOEDEMA; Narrative: a 65yo male with PMH of Cervical Spondylosis w/radiculopathy, Pain in R. Knee, Angioedema (2021), Lumbar Spondylosis, DM, Depressive disorder, Sleep Apnea, CKD, Gout and Exposure to Potentially Hazardous Substance. Per the administering RN's note; on February 11, 2025, the patient received RSV vaccine Pfizer RSV Bivalent, Protein subunit RSVPREF diluent reconstituted 0.5ML, PF, Lot#LG9829, Exp. 10/31/25, NDC#000069034405. Patient was observed by the administering nurse for 15 minutes at which time the nurse reported the patient felt slight swelling of side of the tongue. No rash and no shortness of breath was present. The patient self administered Epi pen in the clinic, PCP assessed the patient and patient remained in the clinic for observation. The patient also took his own prednisone, which he usually does whenever he gets medication reaction, together with epipen. The nurse's note included that the patient has two more epi pen at home. The nurse made follow up phone call and the patient confirmed the symptom has gone down, will take Tylenol for a headache and stating as the RN documented it " I know by the end of the day it will be gone". The ordering physician reported the observed vaccination induced Tongue swelling and updated patient's allergy profile. Other Relevant HX: Other: ANGIOEDEMA OF TONGUE